<- Go home

Added to YB: 2023-07-18

Pitch date: 2023-07-18

HYPE3:BZ [bullish]

Hypera S.A.

-40.96%

current return

Author Info

No bio for this author

Company Info

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands.

Market Cap

BRL 11.7B

Pitch Price

BRL 40.08

Price Target

N/A

Dividend

3.67%

EV/EBITDA

7.84

P/E

7.53

EV/Sales

2.45

Sector

Pharmaceuticals

Category

N/A

Show full summary:
Hypera S.A. HYPE3:BZ

A summary for this pitch has not been created yet.

Read full article (0 min)